Need all Congresses? Press Enter for expanded federal results.

SB 278

Virginia - Session 2026

Senate enrolled 2026-03-14
Bill Details

Title: Federal 340-B Drug Pricing Program; impacts within the Commonwealth.

Summary

Drug manufacturers; permitting and registration; certain conditions related to 340B-covered drugs. Requires a drug manufacturer, as a condition of obtaining a permit or as a condition of registration or renewal of registration, to certify that it does not limit the number of contract pharmacies or covered entities, as defined in relevant law, to which it ships 340B-covered drugs and that it does not impose requirements, exclusions, reimbursement terms, or other conditions on a contract pharmacy or covered entity that differ from those applied to pharmacies or entities that are not contract pharmacies or covered entities on the basis that the pharmacy or entity is a contract pharmacy or covered entity or that the pharmacy or entity dispenses 340B-covered drugs.

Sponsor
Srinivasan
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-13 Introduced Bill introduced
2026-03-14 Status enrolled
2026-03-14 Latest Action Governor's Action Deadline 11:59 p.m., April 13, 2026
More Bills From This Sponsor